[ACRX] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
17-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 261.74%
YoY- 268.87%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 4,825 71 95 27,607 548 407 940 197.26%
PBT 671 -10,575 -9,631 17,769 -10,986 -17,447 -12,762 -
Tax 6,556 2,215 -618 -1,742 -1,980 -9,273 -1,285 -
NP 671 -10,575 -9,631 17,769 -10,986 -17,447 -12,762 -
Tax Rate -977.05% - - 9.80% - - - -
Total Cost 4,154 10,646 9,726 9,838 11,534 17,854 13,702 -54.83%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 13.91 -14,894.37 -10,137.89 64.36 -2,004.74 -4,286.73 -1,357.66 -
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS 0.40 -4.88 -4.46 8.20 -5.30 -9.36 -6.87 -
EPS Diluted -2.60 -4.77 -4.46 8.20 -5.30 -9.36 -6.87 -47.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.